Literature DB >> 33299671

Quantitative sensory testing predicts histological small fiber neuropathy in postural tachycardia syndrome.

Sophia C I Billig1, Joana C Schauermann1, Roman Rolke1, Istvan Katona1, Jörg B Schulz1, Andrea Maier1.   

Abstract

BACKGROUND: Retrospective investigation of the somatosensory profile and prediction of histologic small fiber neuropathy (SFN) in postural orthostatic tachycardia syndrome (POTS) was performed using quantitative sensory testing (QST) as a standardized noninvasive test.
METHODS: In this investigation, full data sets from 30 patients (age: 34.03 ± 10.82 years, n = 6 males), including results of autonomic function testing, norepinephrine values, skin biopsy, and QST, were retrospectively analyzed. The QST data were compared with healthy controls (HCs) (age: 34.20 ± 10.5 years, n = 6 males, t test: 0.95).
RESULTS: The evaluation of all QST parameters in POTS compared with HCs yielded differences in all thermal parameters (cold detection threshold: p < 0.05, warm detection threshold: p < 0.001, thermal sensory limen: p < 0.001, cold pain threshold: p < 0.05, and heat pain threshold: p < 0.001) and in paradoxical heat sensations (p < 0.05). Differences in nonpainful stimuli (mechanical detection threshold: p < 0.05 and vibration detection threshold: p < 0.001) were also detected. All patients who had clinical signs of SFN in combination with impairment of small fibers in QST also had SFN on skin biopsy.
CONCLUSION: These results suggest that a non-region-specific SFN in POTS compared with controls can be detected by noninvasive QST that predicts histologic small fiber pathology.
© 2019 American Academy of Neurology.

Entities:  

Year:  2020        PMID: 33299671      PMCID: PMC7717634          DOI: 10.1212/CPJ.0000000000000770

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  18 in total

1.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.

Authors:  G Lauria; S T Hsieh; O Johansson; W R Kennedy; J M Leger; S I Mellgren; M Nolano; I S J Merkies; M Polydefkis; A G Smith; C Sommer; J Valls-Solé
Journal:  Eur J Neurol       Date:  2010-07       Impact factor: 6.089

Review 2.  Postural orthostatic tachycardia syndrome.

Authors:  A K Agarwal; R Garg; A Ritch; P Sarkar
Journal:  Postgrad Med J       Date:  2007-07       Impact factor: 2.401

3.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Authors:  Robert S Sheldon; Blair P Grubb; Brian Olshansky; Win-Kuang Shen; Hugh Calkins; Michele Brignole; Satish R Raj; Andrew D Krahn; Carlos A Morillo; Julian M Stewart; Richard Sutton; Paola Sandroni; Karen J Friday; Denise Tessariol Hachul; Mitchell I Cohen; Dennis H Lau; Kenneth A Mayuga; Jeffrey P Moak; Roopinder K Sandhu; Khalil Kanjwal
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

4.  Small-fiber neuropathy in patients with ALS.

Authors:  J Weis; I Katona; G Müller-Newen; C Sommer; G Necula; C Hendrich; A C Ludolph; A-D Sperfeld
Journal:  Neurology       Date:  2011-06-07       Impact factor: 9.910

5.  Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values.

Authors:  R Rolke; R Baron; C Maier; T R Tölle; - D R Treede; A Beyer; A Binder; N Birbaumer; F Birklein; I C Bötefür; S Braune; H Flor; V Huge; R Klug; G B Landwehrmeyer; W Magerl; C Maihöfner; C Rolko; C Schaub; A Scherens; T Sprenger; M Valet; B Wasserka
Journal:  Pain       Date:  2006-05-11       Impact factor: 6.961

Review 6.  Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance.

Authors:  Emily M Garland; Jorge E Celedonio; Satish R Raj
Journal:  Curr Neurol Neurosci Rep       Date:  2015-09       Impact factor: 5.081

7.  Small-fiber neuropathy with cardiac denervation in postural tachycardia syndrome.

Authors:  Carl-Albrecht Haensch; Marco Tosch; Istvan Katona; Joachim Weis; Stefan Isenmann
Journal:  Muscle Nerve       Date:  2014-08-29       Impact factor: 3.217

8.  Quantitative autonomic testing.

Authors:  Peter Novak
Journal:  J Vis Exp       Date:  2011-07-19       Impact factor: 1.355

9.  Structural and functional small fiber abnormalities in the neuropathic postural tachycardia syndrome.

Authors:  Christopher H Gibbons; Istvan Bonyhay; Adam Benson; Ningshan Wang; Roy Freeman
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

10.  Autoimmune postural orthostatic tachycardia syndrome.

Authors:  Mari Watari; Shunya Nakane; Akihiro Mukaino; Makoto Nakajima; Yukiko Mori; Yasuhiro Maeda; Teruaki Masuda; Koutaro Takamatsu; Yanosuke Kouzaki; Osamu Higuchi; Hidenori Matsuo; Yukio Ando
Journal:  Ann Clin Transl Neurol       Date:  2018-02-28       Impact factor: 4.511

View more
  4 in total

1.  Observational case series of postural tachycardia syndrome (PoTS) in post-COVID-19 patients.

Authors:  Nicholas P Gall; Stephen James; Lesley Kavi
Journal:  Br J Cardiol       Date:  2022-01-26

2.  Cutaneous alpha-synuclein deposition in postural tachycardia patients.

Authors:  Todd D Levine; Bailey Bellaire; Christopher Gibbons; Roy Freeman
Journal:  Ann Clin Transl Neurol       Date:  2021-03-25       Impact factor: 4.511

3.  Maintenance therapy with subcutaneous immunoglobulin in a patient with immune-mediated neuropathic postural tachycardia syndrome.

Authors:  Kalliopi Pitarokoili; Andrea Maier; Elena C de Moya Rubio; Katrin Hahn; Gerd Wallukat; Diamantis Athanasopoulos; Thomas Grüter; Jeremias Motte; Anna Lena Fisse; Ralf Gold
Journal:  J Transl Autoimmun       Date:  2021-08-14

4.  Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting - Part 2.

Authors:  Satish R Raj; Kate M Bourne; Lauren E Stiles; Mitchell G Miglis; Melissa M Cortez; Amanda J Miller; Roy Freeman; Italo Biaggioni; Peter C Rowe; Robert S Sheldon; Cyndya A Shibao; Andre Diedrich; David M Systrom; Glen A Cook; Taylor A Doherty; Hasan I Abdallah; Blair P Grubb; Artur Fedorowski; Julian M Stewart; Amy C Arnold; Laura A Pace; Jonas Axelsson; Jeffrey R Boris; Jeffrey P Moak; Brent P Goodman; Kamal R Chémali; Tae H Chung; David S Goldstein; Anil Darbari; Steven Vernino
Journal:  Auton Neurosci       Date:  2021-06-30       Impact factor: 2.355

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.